Therapeutic Target For Prostate Cancer Provided By Newly Identified Tumor Suppressor

Scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have identified how an enzyme called PKCζ suppresses prostate tumor formation. The finding, which also describes a molecular chain of events that controls cell growth and metastasis, could lead to novel ways to control disease progression. Working in close collaboration, the labs of Maria T. Diaz-Meco, Ph.D., and Jorge Moscat, Ph.D., found that PKCζ controls the activation of a pro-tumor gene called c-Myc. Normally, PKCζ's alteration keeps c-Myc in check...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/GIrepaLOt_o/258498.php

sport sport medical sport news